Advertisement
SGMO 外匯新聞
Sangamo Inks Evaluation And Option Agreement With Lilly's Prevail For Adeno-associated Virus Capsids
Genomic medicine company Sangamo Therapeutics, Inc. (SGMO) announced Monday it has signed an evaluation and option agreement with Prevail Therapeutics, a wholly owned subsidiary of Eli Lilly and Co. (LLY).
RTTNews
|
672天前
